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Abstract
Purpose Similar to synthetic cannabinoids, synthetic cathinone derivatives are the most popular compounds among novel 
psychoactive substances. Along with a growing number of new cathinones, the number of consumers wishing to enrich their 
experience with these compounds is also growing, and the same can be said about the growing numbers of poisonings. The 
reason for overdosing is a lack of consumer awareness regarding composition of the product, with which they experiment, 
and even more, regarding concentration of psychoactive substances contained in the taken product. In this paper, we report a 
case of the purposeful intake of a high dose of powder containing a novel cathinone derivative, α-propylaminopentiophenone, 
which resulted in the deadly poisoning of a woman.
Methods Aiming to identify this psychoactive substance causing the fatality, the postmortem specimens collected from 
the autopsy was analyzed by means of high-performance liquid chromatography coupled with mass spectrometry, and the 
analysis of a powder material found with the victim was additionally analyzed by means of gas chromatography with mass 
spectrometric detection.
Results In the course of analysis performed on the specimens originating from autopsy (blood, eyeball fluid, liver, kidney 
and brain), high concentrations of α-propylaminopentiophenone were established, which was responsible for the death of a 
young woman. The same psychoactive compound was also identified in the powder material.
Conclusions To the best of the authors’ knowledge, this is the first case reported in the literature on fatal poisoning with 
α-propyloaminopentiophenone.
Keywords Fatal poisoning · Postmortem specimens · Synthetic cathinones · α-Propylaminopentiophenone · N-PP · LC–
MS/MS
Introduction
Although the history of designer drugs is relatively new (as 
it only began in the 1990s of the past century), popularity 
thereof grew rapidly, owing to a fast growing circle of their 
recipients [1, 2]. In Europe, designer drugs became popular 
in the second half of the 1990s; they were first imported 
from New Zealand in the form of tablets known as “party 
pills” and containing piperazine derivatives [2]. The first 
stores selling designer drugs emerged in Holland, Great Brit-
ain and Germany, and the first Polish store was opened in 
2008, in the city of Łódź. The designer drug market is grow-
ing with an astonishing speed, with new drug derivatives 
continuously popping up, whereas identification thereof and 
risk estimation cannot keep up.
Novel psychoactive substances (NPS) pose a huge 
problem for legal and clinical toxicologists. New sub-
stances rapidly emerge on the market, and great similarity 
among the compounds belonging to the same chemical 
group is an additional analytical difficulty. The methods 
for rapid screening of biological material for designer 
drugs have not been elaborated with a sufficient success 
to cover a wide enough spectrum of compounds belonging 
to different chemical groups. Consequently, a chance to 
identify psychoactive compounds with patients turning up 
in hospital wards with a suspicion of poisoning is quite 
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low. The immunochemical tests are limited to selected 
groups of compounds only, but they are not sensitive and 
specific enough to identify NPS selectively, nor enable 
identification of compounds belonging to all NPS groups 
simultaneously [3]. Legal toxicologists working in foren-
sics laboratories identify novel psychoactive substances 
using highly specific analytical tools such as high-per-
formance liquid chromatography–mass spectrometry 
(HPLC–MS) and gas chromatography–mass spectrometry 
(GC–MS), which enable detailed analysis in a wide range 
of NPS compounds [4]. Moreover, it is noteworthy that 
isolation of psychoactive substances from the biological 
matrix is a very difficult practical task, which generates 
the need to elaborate the optimal extraction conditions, 
as extraction is the key step in toxicological analysis of 
biological specimens.
Currently, one of the most popular and also most 
numerous groups among designer drugs are the cathi-
none derivatives. Each year, much reference informa-
tion about synthetic cathinones, which dominate the 
global pseudodrug market, appears in the literature 
[5–7]. Unawareness of consumers regarding compo-
sition of these products, and even more importantly, 
regarding the concentration of a psychoactive com-
ponent in the administered dose is the most frequent 
cause of poisonings, fatalities included. The most recent 
announcements on fatal overdosing of cathinone deriva-
tives referred to α-pyrrolidinobutiophenone (α-PBP), 
α-pyrrolidinovalerophenone (α-PVP), 4-methoxy-PV8 
(4-methoxy-α-pyrrolidinoheptanophenone), 4-meth-
oxy-PV9 (4-methoxy-α-pyrrolidinooctanophenone) 
and α-pyrrolidinoctanophenone (PV9) [8–11]. In this 
study, we report on fatal poisoning with a novel psy-
choactive compound from the cathinone group, namely 
α-propyloaminopentiophenone (N-PP) (Fig. 1) and to our 
best knowledge, this will be the first such case reported 
in the literature.
Case history
According to her partner, the 29-year-old woman suffered 
from depression and alcoholism. She was treated in the past 
in a hospital for being nervously and mentally ill, and failed 
a suicide attempt in 2014. At some point on New Year’s 
Eve 2014, she fought with her partner and left her home. 
At about 12:30 a.m., the woman returned home under the 
influence of alcohol. As her partner testified, the woman 
sat at the table, pulled a bag of white powder out of her 
pocket, took some of its contents on a flat tea spoon, put it 
in her mouth, swallowed it, and then repeated with the same 
portion of the powder again. Then the woman got up and 
went to the bathroom to take a bath. After a short while, her 
partner heard her crying for help. She claimed not to feel 
her legs and was unable to walk on her own. After entering 
the bathroom, the man saw her in convulsions, and then she 
lost consciousness and fell to the floor. He alerted the medi-
cal emergency service and resuscitated her himself. Further 
resuscitation activities were carried out first by the police 
officers and then by the ambulance team. At 02:40 a.m., after 
a few minutes of resuscitative action, the doctor declared the 
woman dead. Autopsy revealed cerebral edema, pulmonary 
edema and passive congestion of internal organs, and it was 
concluded that acute respiratory distress was the direct cause 
of death. During the course of examination of the apartment 
where the death occurred, lines of white powder and blister 
packs with the drugs Sevredol, MST Continus, haloperidol, 
Controloc 20 and amitriptyline were secured.
Materials and methods
Chemicals
All reagents used in this study were of high purity grade 
(HPLC and MS). Acetonitrile, 35% ammonia solu-
tion, ammonium formate, ethyl acetate, formic acid, 
methanol, and water Chromasolv were purchased from 
Fig. 1  Structures of 
α-propylaminopentiophenone 
and pentedrone (internal 
standard)
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Sigma-Aldrich (Saint Louis, MO, USA). Samples of the 
α-propylaminopentiophenone and pentedrone reference 
standards were purchased from Cayman Chemical (Ann 
Arbor, MI, USA). The immunoenzymatic ELISA Forensic 
Drug Test Kits were purchased from Neogen (Lexington, 
KY, USA).
Extraction procedure with biological specimens
Biological specimens preserved for the investigations 
consisted of blood, eyeball fluid, and cuttings from liver, 
kidney, and brain. The preliminary screening of blood 
was carried out with use of the immunoenzymatic ELISA 
technique and it targeted the presence of the compounds 
from the group of synthetic cathinones, including meth-
cathinone, and other drugs such as amphetamine, tricyclic 
antidepressants, Δ9-tetrahydrocannabinol and benzodi-
azepines. For the testing, 50-µL blood specimens were 
diluted with 200 µL buffer provided in the reagent kit of 
the ELISA test.
Active substances contained in the biological speci-
mens were isolated before HPLC–MS analyses by means 
of liquid-liquid extraction. To a 2-mL volume of blood or 
eyeball fluid, 2 mL 15% ammonia (pH 12) and 4 mL ace-
tonitrile containing pentedrone as internal standard (IS) 
(Fig. 1) were added, and the mixtures were ultrasonicated 
for 60 min. Then, in each test tube, 1.0 mL each of the 
mixture was placed (maximum seven tubes), to which dif-
ferent amounts of the target compound and 1.0 mL of ethyl 
acetate were added. Finally, the test tubes were shaken for 
2 h and centrifuged, and the supernatant layer (0.8 mL) 
was collected and evaporated to dryness in a stream of 
nitrogen at ambient temperature. The dry residues were 
dissolved in 1 mL methanol and the samples were trans-
ferred to the glass inserts placed in the vials and they were 
ready for the analyses.
For the cuttings of internal organs (liver, kidney, and 
brain), each 5-g sample was minced and homogenized and 
then extracted according to the protocol, using the follow-
ing reagent volumes: 10 mL 15% ammonia (pH 12), 10 mL 
acetonitrile, 20 mL ethyl acetate, and 2 mL methanol.
Extraction procedure with the powder found 
at the scene
A 10-mg sample of the white powder was dissolved in 
1 mL of acetonitrile/methanol (50:50, v/v), ultrasonicated 
for 10 min and then centrifuged. The 10-μL aliquot of the 
obtained sample extract was diluted by adding 990 μL ace-
tonitrile/methanol (20:80, v/v). This diluted sample extract 
was transferred to the glass insert and vial, and then ana-
lyzed by means of HPLC–MS or GC–MS.
HPLC–MS
The qualitative and quantitative HPLC analysis was carried 
out using a UHPLC Dionex Ultimate 3000 liquid chroma-
tograph (Dionex, Sunnyvale, CA, USA) connected to a TSQ 
Endura mass spectrometer (Thermo Scientific, Waltham, 
MA, USA). The chromatograph was equipped with an 
RP-MS Accucore column (100 × 2.1 mm; Thermo Scien-
tific). Mobile phase was composed of solvent A (0.02 M 
aqueous solution of formic acid and 0.05 M aqueous solu-
tion of ammonium formate) and solvent B (10% solvent 
A and 90% acetonitrile). The analyses were carried out in 
the gradient mode, using the following gradient: 0–2 min, 
95% A + 5% B; 2–30 min, 30% A + 70% B; 30–32 min, 30% 
A + 70% B; 32–40 min, the volume ratio was returning to the 
initial one (95% A + 5% B). The mobile phase flow rate was 
100 µL/min. Samples were ionized in the electrospray ioni-
zation (ESI) mode with positive ionization, and the ion mon-
itoring range was m/z 50 to 500.  The temperature of the ion 
source was 250 °C; nitrogen was the carrier gas and helium 
was the ionization gas. For the selected reaction monitoring 
(SRM) mode, the ion transitions were m/z 220.1→ 202.1 and 
m/z 192.1→ 174.1, for α-propylaminopentiophenone and IS, 
respectively. The results obtained were processed with use 
of the Xcalibur v. 4.0. program.
GC–MS
The GC–MS analysis was carried out with use of the 
Trace 1310 model gas chromatograph (Thermo Scientific) 
equipped with the  Rxi®-5Sil MS column (15 m × 0.25 mm, 
film thickness 0.2 µm; Restek, Bellefonte, PA, USA) coupled 
with the TSQ 3000 Thermo Scientific mass spectrometer 
(Thermo Scientific). The employed working conditions: the 
injector temperature, 260 °C; the oven temperature, 100 °C 
for 2 min, then the temperature rise to 260 °C at the rate of 
20 °C/min; the carrier gas, helium, its flow rate, 1.2 mL/
min; the temperature of the MS source, 250 °C; the injec-
tion volume, 1 μL. The obtained mass spectra in the posi-
tive electron ionization (EI) mode were compared with the 
spectra from the Cayman Chemical EI mass spectra library 
(2017) (Cayman Chemical).
Standard addition method
In order to quantify α-propylaminopentiophenone in the 
autopsy specimens, the standard addition method was 
employed. This method can overcome the matrix effects 
and recovery rate differences [9, 10]. Moreover, the method 
requires no blank human specimens that are negative for 
a target compound. It is true that the collection of blank 
human tissue samples is problematic for ethical reasons. On 
the other hand, that method can be used by entities that do 
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not have the possibility to acquire blank biological speci-
mens. To obtain a single concentration value, a calibration 
curve established with the seven concentrations equal to 
20, 50, 100, 200, 500, 1000 and 5000 ng/mL of the target 
compound needs to be constructed. The different concen-
trations of target compound and fixed concentrations of IS 
were added to each portion of the same matrix as described 
before. The minus concentration where the straight standard 
addition calibration curve intersected with the horizontal 
x-axis of target compound concentration showed the existing 
concentration of the target compound in the matrix.
Matrix effects and recovery rates
First, to determine matrix effects and recovery rates in 
all analyzed fluids and tissues, a concentration of target 
compound in each matrix was measured by the standard 
addition method. Then, we prepared a reference stand-
ard α-propylaminopentiophenone methanol solution at 
the concentration, which could be expected in the finally 
reconstituted methanol solution assuming that the extrac-
tion recovery of the target compound was 100% for each 
matrix, which corresponded to the below methanol solu-
tion C. Each matrix was prepared in the procedure described 
before with addition of IS in the early step. At the final step, 
where 1 mL (for fluid) and 2 mL (for solid tissues) of pure 
methanol was added and mixed to reconstitute the sample 
extract residue after evaporation. In addition, 1 or 2 mL of 
the methanol solutions containing the 100% recovery final 
concentrations of α-propylaminopentiophenone was added 
to another sample extract residue and mixed. Therefore, 
there are three types of methanol solution to be injected to 
HPLC–MS. The one obtained from a matrix after recon-
stitution of the sample extract residue with pure methanol 
was denoted as B (by means of peak area); the one obtained 
after reconstitution with methanol containing the 100% 
recovery concentration of the target compound for the same 
sample extract was denoted as A (by means of peak area). 
The methanol solution without any reconstitution, but only 
with the above 100% recovery concentration of the target 
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Fig. 2  Electron ionization mass spectrum of α-propylaminopentiophenone obtained by gas chromatography–mass spectrometry from the powder
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compound was described as C (neat sample). The matrix 
effect and recovery rate were calculated as follows. Matrix 
effect (%) = [(A − B)/C] × 100. Recovery rate (%) = [B/
(A − B)] × 100.
Results and discussion
GC–MS mass spectrum obtained from the powder
The EI-MS spectrum originating from the GC–MS analy-
sis was checked with use of the mass spectrum included 
in the Cayman Chemical Library, which suggested 
α-propylaminopentiophenone as the major ingredient of 
the powder. Then, the spectrum and retention time of the 
ingredient were confirmed to be identical with those of ref-
erence standard of α-propylaminopentiophenone. The peak 
at m/z 114.11 appeared as the base peak, and the peaks at 
m/z 105.03, 77.12 and 58.07 appeared as fragmentation ions 
(Fig. 2). The total ion current chromatogram showed that the 
peak area of α-propylaminopentiophenone constituted 90% 
of the sum of peak areas, suggesting its purity at about 90%.
Electrospray ionization product ion spectrum 
obtained from the powder
The protonated molecular ion [M +  H]+ at m/z 220.17, 
which was obtained from the white powder, underwent fur-
ther MS/MS fragmentations in the positive ionization mode. 
The  MS2 spectrum valid for the ion at m/z 202.11 suggested 
elimination of one molecule of water [M + H − H2O]+. This 
transition is well recognized and characteristic of the com-
pounds belonging to the cathinone group, which suggests 
the presence of such compound in the analyzed sample 
[12]. Other product ions with the m/z values of 175.11 and 
160.11, respectively, corresponded well with the structural 
fragments of α-propylaminopentiophenone (Fig. 3.)
The ELISA tests
As a result of screening of biological samples, the blood 
specimen with use of the immunoenzymatic ELISA test, 
showed the positive response for the synthetic cathinones. 
Because of the lack of similar tests with antibodies valid for 
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Fig. 3  Product ion spectrum of α-propylaminopentiophenone obtained from the powder sample found at the scene together with the proposed 
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Fig. 4  Selected reaction moni-
toring chromatograms obtained 
from high-performance liquid 
chromatography with tandem 
mass spectrometric detection of 
α-propylaminopentiophenone 
for the specimens of a blood, b 
eyeball fluid, c liver, d kidney, 
and e brain
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eyeball fluid, liver, kidney and brain, the ELISA screening 
tests for the remaining organs could not be performed.
HPLC–MS analysis of the powder and human 
specimens
By analysis in the SRM mode of the powder, the 
α-propylaminopentiophenone reference standard, and the 
biological specimens, the chromatograms were obtained with 
the peak at the retention time in the range of 3.79–3.83 min. 
The SRM chromatograms showed only a single peak of the 
target compound; no other impurity peaks ever appeared 
for any specimen (Figs. 4a–e). The ESI product ion spectra 
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Fig. 5  Product ion spectra of α-propylaminopentiophenone for the specimens of a blood, b eyeball fluid, c liver, d kidney, and e brain
Table 1  Standard addition calibration equations and correlation coef-
ficients for α-propylaminopentiophenone in human specimens col-
lected at autopsy
Human specimen Equation Correlation 
coefficient (r)
Blood y =0.3264 x +0.0223 0.998
Eyeball fluid y =0.0997 x +0.2684 0.996
Liver y =0.1147 x +0.0954 0.997
Kidney y =0.2244 x +0.1090 0.995
Brain y =0.8992 x +0.2151 0.995
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showed only the peaks due to α-propylaminopentiophenone 
for all specimens; no impurity peaks appeared (Fig. 5a–e).
Quantitative analysis of human samples
The standard addition calibration equations and their 
correlation coefficients (r) for body fluids and solid tis-
sues are shown in Table 1. The limit of detection [LOD, 
signal-to-noise (S/N) ratio = 3] and limit of quantification 
(LOQ, S/N ratio = 10) were calculated. The LOD and LOQ 
values were 9.0 and 27.2 ng/mL for body fluids and 15.0 
and 46.0 ng/g for solid tissues, respectively. Because we 
did not have blank human specimens, it was not possi-
ble to present usual accuracy and precision. However, we 
evaluated the intraday and interday repeatability of tar-
get compound for each matrix. The results are shown in 
Table 2. The relative standard deviations (RSD) of intra-
day and interday repeatabilities were 6.4–22% except for 
interday brain measurement (RSD = 40%). As also shown 
in Table 2, among five specimens tested, the highest con-
centration of α-propylaminopentiophenone was observed 
(5.9–6.0 µg/g) in the liver, while the lowest one was found 
in the brain (2.1–2.3 µg/g). As described earlier, we have 
also evaluated the matrix effects and recoveries for each type 
of biological specimens and the results are shown in Table 3. 
The matrix’s largest influence was observed in the brain, 
whereas the highest recovery was in the liver, although all 
data were within the acceptable range.  
From the literature, it is known that the range of con-
centrations for the cathinone derivatives established in 
the tissues collected from fatal cases is very wide and it 
largely depends on the type of the analyzed biological 
specimens, as well as on additional circumstances pre-
ceding the death [8–11, 13]. Concentrations of cathinone 
derivatives in autopsy blood obtained from cadavers so 
far reported in the literature have been in the range of 
0.082–22 µg/mL [14]. In these cases, when passing away 
takes place soon after overdosing on a given designer 
drug, its concentrations in the organs are usually high. 
When the detoxication attempts (e.g., through gastric lav-
age or intravenous infusion) are performed prior to the per-
son’s passing away, concentration of a given cathinone in 
the postmortem blood is lower, which seems quite logical 
[15]. In the case reported in this reference, prior to death 
the person underwent an intense detoxication process, so 
that concentrations of PV9 established in nine different 
body tissues were in the range from 0.212 to 0.907 µg/g. 
Concentrations of cathinone derivatives such as 4-meth-
oxy-PV8, PV9 and 4-methoxy-PV9 in the postmortem 
blood of a young woman who most probably died shortly 
after a simultaneous intake of all three was 2.69, 0.743 and 
0.261 µg/mL, respectively [11]. Ethyl alcohol was addi-
tionally found at the 1.52 mg/mL level in the postmortem 
blood of the deceased woman, which might addition-
ally strengthen toxic action of the cathinone derivatives. 
Nevertheless, damage of internal organs due to an intake 
of high amounts of synthetic cathinones which quickly 
penetrate to the bloodstream is enough to result in pass-
ing away, independent of earlier undertaken detoxication 
attempts.
Concentrations of α-propylaminopentiphenone found in 
blood, eyeball fluid, liver, kidney and brain of the deceased 
reported in this study were very high (Table 2) and they 
clearly explain rapid reaction of the young woman’s organ-
ism and her eventual quick death. It happened due to an 
intake of high quantities (two spoonfuls) of the drug powder 
(probably ± 10 g), whereas the average portions taken by 
non-addicts range between 20 and 200 mg powder [16].
Conclusions
As a result of the postmortem analysis of blood, eye-
ball fluid, liver, kidney, and brain, high concentrations 
of α-propylaminopentiophenone in these organs were 
disclosed. Based on known circumstances of deaths 
in combination with the analytical data obtained, the 
Table 2  Evaluated intraday and interday repeatability for determina-
tion of α-propylaminopentiophenone in each human specimen
RSD relative standard deviation
a Data were expressed as mean ± standard deviation (SD)
Specimen Intraday (n = 5) Interday (n = 5)
Concentra-
tiona (µg/mL 
or g)
Repeat-
ability (% 
RSD)
Concentra-
tiona (µg/mL 
or g)
Repeat-
ability (% 
RSD)
Blood 3.2 ± 0.68 21 3.1 ± 0.23 7.4
Eyeball fluid 4.4 ± 0.52 12 4.2 ± 0.90 21
Liver 5.9 ± 0.38 6.4 6.0 ± 0.66 11
Kidney 5.4 ± 0.92 17 5.4 ± 1.20 22
Brain 2.3 ± 0.50 22 2.1 ± 0.85 40
Table 3  Matrix effects and recovery rates for determination of 
α-propylaminopentiophenone in each human specimen
Data given as mean ± SD (n = 3)
Specimen Matrix effect ± SD 
(%)
Recovery ± SD (%)
Blood 74.1 ± 4.6 75.5 ± 5.0
Eyeball fluid 70.3 ± 5.8 71.3 ± 3.6
Liver 84.8 ± 3.2 82.6 ± 3.2
Kidney 80.3 ± 4.7 72.8 ± 1.6
Brain 68.8 ± 6.4 64.3 ± 3.4
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young woman seemed susceptible to fatal poisoning by 
α-propylaminopentiophenone from the cathinone group. 
To the authors’ best knowledge, this is the first case report-
ing fatal poisoning with a novel psychoactive compound 
α-propyloaminopentiophenone.
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